| 摘要 |
<p>The invention concerns in particular a nucleotide sequence comprising at least a sequence having at least 75 % identity with the gene coding for the GABAA epsilon 2 receptor subunit, the peptide corresponding to the epsilon 2 subunit, a method for screening active substances on the central nervous system, and a pharmaceutical composition comprising said substances.</p> |
